BMRN

BioMarin Pharmaceutical Inc. News Headlines

$60.89
*  
0.48
 negative 
0.78%
Get BMRN Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
4/16/2014 10:07:01 AM - Zacks.com

Good News for BioMarin - Analyst Blog
4/15/2014 7:05:01 PM - Zacks.com

BioMarin Pharma Says FDA Extends Market Exclusivity Six Months For Kuvan Powder
4/14/2014 8:26:00 AM - RTT News

Cramer's Lightning Round - The IPOs Are A Curse On The Market (4/10/14)
4/11/2014 6:25:00 AM - Seeking Alpha

Venture Capitalist Ran Nussbaum Brings Big Finance To Little Biotechs
4/4/2014 8:31:00 AM - Seeking Alpha

BioMarin Pharmaceutical (BMRN) Shares Cross Below 200 DMA
3/27/2014 1:14:57 PM - BNK Invest

BBH, ALKS, BMRN, ISIS: Large Outflows Detected at ETF
3/27/2014 11:37:34 AM - BNK Invest

Good News for Catalyst Pharma - Analyst Blog
3/26/2014 6:30:01 PM - Zacks.com

Avoid Applied Genetic Technologies IPO
3/26/2014 9:58:00 AM - Seeking Alpha

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia

Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog
3/20/2014 9:20:01 AM - Zacks.com

BioMarin Expects Proceeds Of $119 Mln. From 1.5 Mln. Share Offer
3/5/2014 11:44:00 AM - RTT News

Biomarin Pharma. To Present At Cowen & Co. Conference; Webcast At 11:20 AM ET
3/4/2014 10:20:00 AM - RTT News

BioMarin Pharmaceutical Larger Than S&P 500 Component Newmont Mining
2/28/2014 5:51:19 PM - BNK Invest

Interesting BMRN Put And Call Options For October 18th
2/26/2014 12:39:59 PM - BNK Invest

Biomarin Pharma. To Present At RBC Capital Conference; Webcast At 8:30 AM ET
2/26/2014 7:30:00 AM - RTT News

Is NPS Pharmaceuticals The Next Alexion?
2/25/2014 9:56:00 AM - Seeking Alpha

BioMarin Rises on Favorable CHMP Opinion - Analyst Blog
2/21/2014 4:05:01 PM - Zacks.com

BMRN Awaits EMA Nod, KIN Hits A High, Nuvilex Gets Rich, OHRP A Sight Better
2/20/2014 10:38:00 PM - RTT News

Strong 2014 Sales Guidance from BioMarin - Analyst Blog
2/19/2014 6:50:01 PM - Zacks.com

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog
2/19/2014 10:27:01 AM - Zacks.com

Rare Early Success Of Ultragenyx Pharmaceuticals Could Continue With Expiration Of Quiet Period
2/18/2014 2:27:00 PM - Seeking Alpha

FDA Clears BioMarin's Vimizim - Analyst Blog
2/18/2014 1:10:01 PM - Zacks.com

BioMarin Pharma Expects FY13 Loss Of $185 - $160 Mln
2/17/2014 7:12:00 PM - RTT News

BioMarin Pharma Gets FDA Approval For VIMIZIM - Quick Facts
2/14/2014 5:25:00 PM - RTT News